• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cytos Biotechnology AG

+ Add to Watchlist

CSBTF:US

Snapshot for Cytos Biotechnology AG (CSBTF)

Open: - Day's Range: - Volume: 0
Previous Close: 0.2700 52wk Range: 0.1589 - 4.0000 1-Yr Rtn: -

Stock Chart for CSBTF

No chart data available.
  • CSBTF:US 0.2700
  • 1M
  • 1Y
0.2700
Interactive CSBTF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSBTF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) -0.9150
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 30.53
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSBTF

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for CSBTF

Cytos Biotechnology AG develops and produces biopharmaceuticals. The Company produces vaccines that immunize the patient against disease related proteins. This instructs the immune system to produce antibodies to reverse or prevent disease progression. Cytos develops treatments for immunology and inflammation disorders, cancer and cardiovascular, nervous system, and infectious diseases.

Christian ItinChairman/CEOHarry WeltenExec VP/CFO
Matthias AlderExec VP:Corporate DevelopmentFrank HenneckeExec VP:Product Dev
More Company Profile & Key Executives for CSBTF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil